Skip to main navigation Skip to search Skip to main content

An Interventional, Phase 3 Extension Study to Investigate Long-Term Safety and Tolerability of Tolebrutinib in Participants with Relapsing Multiple Sclerosis, Primary Progressive Multiple Sclerosis of Nonrelapsing Secondary Progressive Mult

Project: Research

Project Details

StatusActive
Effective start/end date03/12/2410/25/26

Funding

  • Sanofi US Services Incorporated: $88,481.00